Monthly Archives: September 2016

The results showed a favorable compatibility and indicated biological activity.

The results showed a favorable compatibility and indicated biological activity. With the mechanism ZymoGenetics and its partner, Serono SA plan, the full results of this clinical trial at a medical conference to introduce later this year. ‘These positive results show the potential of atacicept for the treatment of patients with SLE,’said Nicole Onetto, Senior Vice President and Chief Medical Officer of ZymoGenetics. ‘We are very encouraged by the impressive results… Read Article →

Creating a knockout rat was facing the biggest challenge OMT.

‘Creating a knockout rat was facing the biggest challenge OMT,’said Dr. Roland Buelow, CEO of OMT and senior author of the paper ‘the inactivation of endogenous. Rat antibody is an expression of the human antibody expression essential in genetically modified animals. To solve this problem, we investigated a new application for Zinc Finger nuclease technology, a technique that could revolutionize the genetic modification of animals activated. ‘. Used in the… Read Article →